|
Re: Will we be changing the name of this site to GRB7 support soon?
This kind of research can possibly lead to future therapies that will help treat and possibly defeat Her2 positive cancers. But in the meantime, I am unclear how knowing whether we have this gene expression or not would change the treatment regimens currently used. Seems like they found the GRB7 gene is present when Her2 is over expressed. We can now find out if we have the Her2 over expression and start treatments based on that information. What would be different if we also knew the GRB7 status? Would this possibly open up the use of anti-Her2 drugs for Her2 negative cases? I'm apparently missing something here---
bird
__________________
Male Breast Cancer, DX 5/15/09, IDC, STAGE 1, 1.7 cm, HER2+++, ER+(95%)/PR+(75%), Ki67 40%, grade 3, 0/5 nodes, TX: mastectomy, TCH finished 7/19/10, radiation 6 wks., Tamoxifen on going, bisphosphonate 24 mos.
|
Threaded Mode